Long-term Efficacy and Safety Study With Oralgen Grass Pollen
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to give additional information on the efficacy, safety and local
effects (tolerability) of a dose of sublingual immunotherapy administered once a day, during
a second grass pollen season.